watchAnecdotalApr 27, 2026
Access rumor correction
Some community posts are pushing back against overconfident claims that FDA review equals immediate pharmacy availability.
Reddit / r/PeptideProgressmedium confidencereddit
Source BPC-157
Body Protection Compound-157 · Bepecin · PL 14736
Tissue RepairCategory 2Phase IIResearchSubQIM
Popular for:Injury recovery, gut healing, tendon and ligament repair
2
Registered Trials
0
Trial Publications
203
PubMed References
Phase II
Evidence Level
Overview
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a naturally occurring protective protein found in human gastric juice. The short version: people usually care about it for injury recovery, gut healing, tendon and ligament repair, but the strength of the evidence depends heavily on indication and study type.
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a naturally occurring protective protein found in human gastric juice. It is one of the most extensively studied healing peptides, with hundreds of animal studies demonstrating powerful tissue repair, gut healing, and anti-inflammatory properties.
**Originally developed for: **Gastrointestinal protection and healing. It was identified as a stable fragment of human gastric juice protein BPC, and initially studied for its cytoprotective effects on the GI tract, including protection against NSAID-induced damage and ulcers.
Research Snapshot
What the evidence says
Phase IIBPC-157 currently shows 2 registered trials from ClinicalTrials.gov, 0 PubMed trial publications (0 RCT-tagged), and 203 PubMed references matching the stored source query. Treat PubMed references as literature surface area, not a count of clinical trials.
Known vs uncertain
Known signals
- 2 registered trials are tracked from ClinicalTrials.gov intervention records.
- 0 PubMed clinical-trial publications are indexed.
- 0 PubMed randomized controlled trial publications are indexed.
- 203 PubMed references are tracked separately from trial counts and can include animal, in-vitro, review, mechanism, or clinical records.
Open questions
- Evidence strength may vary by indication, route, formulation, and population.
- Public anecdotes can highlight interest or concern but do not establish clinical efficacy.
- Regulatory status and compounding access can change independently from the research literature.
Mechanism of Action
BPC-157 works through multiple overlapping pathways.
Key Research Benefits
Primary Benefits:
Accelerated tendon and ligament healing — improved biomechanical properties in rat Achilles tendon studies (Chang et al., 2011; Staresinic et al., 2003)
Gastrointestinal protection — heals ulcers, protects against NSAID-induced gut damage, beneficial for IBD and leaky gut (Sikiric et al., 2006)
Muscle and bone healing — promotes faster recovery from crush injuries and fractures (Novinscak et al., 2008)
Angiogenesis — promotes new blood vessel formation at injury sites via VEGF upregulation (Hsieh et al., 2016)
Secondary/Emerging Benefits:
Neuroprotection — protects against dopaminergic neurotoxins, potential for traumatic brain injury recovery (Vukojevic et al., 2020)
Cardioprotection — studies show protective effects in heart failure, arrhythmias, and thrombosis models
Liver protection — prevented and reversed alcohol-induced liver damage in rat studies (Sikiric et al.)
Anti-depressant-like effects — modulates dopamine and serotonin systems
Clinical Evidence Summary
Research Pipeline
Preclinical
Animal
Phase I
Phase II
Phase III
Approved
2
Registered Trials
0
Trial Publications
0
RCT Publications
203
PubMed References
ClinicalTrials.govPubMed ESearchExact-name queryChecked May 4, 2026
Registered trials are ClinicalTrials.gov intervention records. Trial publications are PubMed records tagged as clinical trials or randomized controlled trials. PubMed references are broader source-query matches and can include animal studies, in-vitro work, reviews, mechanism papers, and trial publications.
2
Registered trials
0
Trial publications
0
RCT publications
203
PubMed references
42
Reviews
0
Meta-analyses
Registered trials source
Jun 1, 2026
BPC-157, BPC 157, PCO-02
Uses curated ClinicalTrials.gov intervention aliases to avoid misleading registry matches.
View source- Sikiric et al. (2006, 2010, 2014) — Extensive body of work across 100+ studies showing tissue repair, GI protection, and anti-inflammatory effects in rats. The foundational research for BPC-157.
- Chang et al. (2011, 2014) — Demonstrated BPC-157 promotes tendon healing via outgrowth, cell survival, cell migration, and upregulation of growth hormone receptors in tendon fibroblasts.
- Hsieh et al. (2016) — Showed BPC-157's pro-angiogenic effects are mediated by VEGFR2 activation.
- Vukojevic et al. (2020) — Demonstrated protective effects against hippocampal ischemia/reperfusion injuries in rats.
- PMC systematic review (2024) — Comprehensive orthopaedic sports medicine review synthesizing all available BPC-157 literature.
> Clinical trial status: No completed human clinical trials as of 2026. All evidence is from animal studies (primarily rats). Despite this, it is increasingly used by clinicians and athletes.
Key PubMed References
203 PubMed references · showing top 25 by relevance
View all on PubMedMultifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review.
Review
Józwiak M, Bauer M, Kamysz W, et al. · Pharmaceuticals (Basel, Switzerland) · 2025
PMID: 40005999Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.
Review
Sikiric P, Seiwerth S, Skrtic A, et al. · Pharmaceuticals (Basel, Switzerland) · 2025
PMID: 40573323Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.
Meta-Analysis
Vasireddi N, Hahamyan H, Salata MJ, et al. · HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2025
PMID: 40756949Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant and is believed to protect the gastro-intestinal tract (GIT).
Review
Whitehouse M · Inflammopharmacology · 2025
PMID: 40759852Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.
Review
McGuire FP, Martinez R, Lenz A, et al. · Current reviews in musculoskeletal medicine · 2025
PMID: 40789979Anecdotes & Sentiment
Public discussion, not clinical evidence
This section summarizes what people are talking about in public sources. It can be useful for spotting questions, hype cycles, and recurring concerns, but it is separate from the evidence sections above.
watchAnecdotalApr 16, 2026
FDA docket attention
BPC-157 discussion is clustering around the FDA PCAC docket, with users trying to infer what a future review could mean for access.
Reddit / r/bpc_157medium confidencereddit
Source mixedAnecdotalFeb 24, 2026
Mainstream wellness attention
Mainstream coverage frames BPC-157 as part of a wider social-media peptide boom that moved beyond niche bodybuilding forums.
TIMEhigh confidencemedia
Source Side Effects & Safety
**Common Side Effects:** - Mild nausea (more common with oral dosing) - Brief lightheadedness after injection - Injection site redness/irritation - Mild fatigue (uncommon) **Rare but Serious Risks:** - Theoretical concern with angiogenesis: promoting blood vessel growth could theoretically accelerate tumor growth in someone with pre-existing cancer.
Common Side Effects:
Mild nausea (more common with oral dosing)
Brief lightheadedness after injection
Injection site redness/irritation
Mild fatigue (uncommon)
Rare but Serious Risks:
Theoretical concern with angiogenesis: promoting blood vessel growth could theoretically accelerate tumor growth in someone with pre-existing cancer. No evidence of this occurring, but it's the primary safety concern discussed in the literature.
No lethal dose (LD50) was found even at very high concentrations in toxicology studies
> Contraindications: Individuals with active cancer or a history of cancer should avoid BPC-157 due to its angiogenic properties. Not recommended during pregnancy or breastfeeding. No known drug interactions, but caution is warranted when combining with other peptides that affect the NO system.
Known Interactions
No curated interaction entry is live for BPC-157 yet.
Until the interaction table is fully populated, use the interaction checker and related peptides below to explore adjacent compounds and likely research pairings.
Comparison Pages
Frequently Asked Questions
Research Disclaimer
This page is for research and educational purposes only. The information presented is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Regulatory status can vary by compound, formulation, indication, and jurisdiction. Check official labeling, registry records, and qualified professional guidance before making any health-related decision. The studies referenced are linked to their original PubMed sources for verification.